You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML IL-6 SILTUXIMAB

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)

Recruiting
  • Non-Hodgkin Lymphoma
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jan 13, 2023

Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU de Nantes
Jan 24, 2023

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Siltuximab
  • Spartalizumab
  • Atlanta, Georgia
  • +2 more
Feb 1, 2022

Anti-IL6 and Corticosteroid Monotherapy vs Combination in

Recruiting
  • Critical Illness
  • +2 more
  • Interleukin 6 (IL6) Antagonist
  • +2 more
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital and Research Center
Mar 4, 2021

Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

Active, not recruiting
  • Multiple Myeloma
  • AL Amyloidosis
  • Siltuximab
  • The M.D. Anderson Symptom Inventory (MDASI)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Leukemia, Acute Myeloid (AML) Trial in Worldwide (gilteritinib, LoDAC (Low Dose Cytarabine), Azacitidine)

Active, not recruiting
Has Results
  • Leukemia, Acute Myeloid (AML)
  • Birmingham, Alabama
  • +125 more
Aug 9, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Acute Myeloid Leukemia, Vitamin D Deficiency, ADAMTS13 Trial in Cairo (Cholecalciferol 2800 I.U. ml oral drops)

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • Cholecalciferol 2800 I.U. ml oral drops
  • Cairo, Madinaty, Egypt
    Dina Ashraf Abdelhady
Nov 25, 2021

Schizophrenia, Psychotic Disorders Trial in Augusta (Siltuximab, normal saline)

Recruiting
  • Schizophrenia
  • Psychotic Disorders
  • Augusta, Georgia
    Augusta University
Jul 27, 2021

Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

Completed
  • Acute Myelogenous Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 4, 2023

High-risk Smoldering Multiple Myeloma Trial in Worldwide (Siltuximab, Placebo)

Completed
Has Results
  • High-risk Smoldering Multiple Myeloma
  • Chicago, Illinois
  • +39 more
Jan 23, 2020

IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.

Withdrawn
  • Critical Illness Sepsis, Severe
    • (no location specified)
    Jun 13, 2022

    Immunophenotypic Evaluation of IL-7R a in Acute Leukaemia

    Not yet recruiting
    • Benefit: To Patient Have Investigation for Diagnosis and Follow up for His Disease and Reach to New Method Help in Early Diagnosis of Lymphoid Disorder
      • (no location specified)
      Nov 30, 2022

      Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +5 more
      • Cytokine Induced Memory-like Natural Killer Cells
      • Interleukin-2
      • Boston, Massachusetts
      • +1 more
      Nov 14, 2023

      Acute Myeloid Leukemia Trial in Baltimore (Dose Escalation -tagraxofusp-erzs, Dose Expansion at RP2D -tagraxofusp-erzs)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Dose Escalation -tagraxofusp-erzs
      • Dose Expansion at RP2D -tagraxofusp-erzs
      • Baltimore, Maryland
        The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Jan 27, 2023

      New Cytokine-based Dynamic Stratification Based on FLt3 Ligand

      Recruiting
      • Acute Myeloid Leukemia
      • No intervention
      • Strasbourg, Bas-Rhin, France
      • +24 more
      Aug 25, 2021

      COVID-19 Trial in Belgium (Usual Care, Anakinra, Siltuximab)

      Completed
      • COVID-19
      • Usual Care
      • +3 more
      • Brugge, Belgium
      • +14 more
      Sep 28, 2021

      Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

      Recruiting
      • Acute Myeloid Leukemia
      • Venclexta 100 MG Oral Tablet
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital with Nanjing Medical University
      Jun 11, 2023

      Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

      Withdrawn
      • Leukemia
      • Donor Enriched Activated Natural Killer Cell Infusion
      • (no location specified)
      Dec 20, 2022

      Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

      Active, not recruiting
      • Acute Myeloid Leukemia (AML)
      • Nantes, France
        CHU of Nantes
      Dec 16, 2022

      Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • CIML NK
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Jan 6, 2023

      Idiopathic Multicentric Castleman's Disease Trial in Lansing (Siltuximab)

      Terminated
      • Idiopathic Multicentric Castleman's Disease
      • Lansing, Michigan
        Edward W. Sparrow Hospital
      Apr 15, 2021

      Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain

      Recruiting
      • Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
      • Quantitative Real Time Polymerase chain reaction (qRT-PCR)
      • ELISA and colorimeter
      • Assiut, Egypt
        Biochemistry department,Faculty of medicine
      Oct 10, 2023

      Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Jerusalem, Yerushalayim, Israel
        Shaare Zedek Medical Center
      Oct 25, 2022

      Symphony IL-6 Study in Patients at Risk of Severe Sepsis

      Recruiting
      • Severe Sepsis
        • Ann Arbor, Michigan
          University of Michigan Medical Center
        Dec 27, 2022